"Great insight into emerging global challenges."
- S. Suggett, Genentech Inc, Senior Product Manager, Global Supply Chain
"Very interesting and important contract manufacturing concepts were discussed ."
- E. Zarther, Merck Research Fellow, Bioprocess Analytical & Formulation Science
IBC's 5th International Outsourcing Manufacturing of Biopharmaceuticals was one of 5 conferences that took place during Biopharmaceutical Development & Production Week which took place on March 2-6, 2009 in Carlsbad, CA.
The focus of this year's conferences was New Contract Manufacturing Approaches to Minimize Cost, Reduce Risk and Ensure Quality. Attendees gathered for this two day conference to:
Conference Highlights Included:
Keynote Presentation:
The Changing Outsourcing Landscape - Strategic Drivers & Solutions
Arindam Bose, Ph.D.
Executive Director of Biologics Strategy & Alliances, Worldwide Pharmaceutical Sciences
Pfizer Global R&D
Featured Session:
Traversing the Antibody Drug Conjugates Supply Chain Obstacle Course
Genentech and ImmunoGen team members will present extensive case studies, actual experiences, lessons learned, and insight into the CMO selection process when outsourcing antibody drug conjugates (ADC's).
Session Topics Covered:
This conference was conveniently co-located with Technology Transfer and Process Validation for Biopharmaceuticals giving attendees access to these additional conferences and networking in the shared exhibit hall which featured over 33 booths.
Planning is now underway for Biopharmaceutical Development & Production week 2010 which will return to the La Costa Resort and Spa on March 1-5, 2010. Join the Outsourcing Manufacturing of Biopharmaceutical priority contact list for latest updates on this conference for 2010!
Copyright IBC Life Sciences, a part of Informa Life Sciences Group